DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...
New research offers unprecedented insight into how an enigmatic enzyme, known as CDK7, drives the cell cycle and cell proliferation.
Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...
Inquirer Business on MSN5h
PT&T, Netlinkz building cybersecurity lab in PhilippinesPT&T Corp. and Australian technology company partner Netlinkz Ltd. will build a "multi-million dollar" software laboratory in ...
A new discovery has shed new light on the crucial role of the CD47 protein in bone fracture healing. Scientists have ...
Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
Mouse study reveals beneficial bacteria play crucial role in helping insulin-producing cells multiply. Exposure to ...
Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer Society. Some of the most high-risk cases are driven by elevated ...
We're one step closer to not just treating baldness but preventing it, with scientists making an important discovery that ...
As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback